Deepak Nitrite Limited

₹ 1,922 Crore

RESPONSIBLE CHEMISTRY Q2 & H1 FY2026 Results Presentation 13 November, 2025 ₹ 1,922 Crore ₹ 224 Crore Total Revenue (in Q2 FY26) EBITDA (in Q2 FY26) 34+ Products 56+ Applications 1,5

₹ 224 Crore

RESPONSIBLE CHEMISTRY Q2 & H1 FY2026 Results Presentation 13 November, 2025 ₹ 1,922 Crore ₹ 224 Crore Total Revenue (in Q2 FY26) EBITDA (in Q2 FY26) 34+ Products 56+ Applications 1,500+ Customers

₹8,366 Crore

s Rich Legacy of over 5 Decades 2 7 Modern Manufacturing Facilities at 5 strategic locations ₹8,366 Crore FY25 Total Revenue 1,500+ Customers 34+ Products 50+ Countries receive our exported product

rs 34

anufacturing Facilities at 5 strategic locations ₹8,366 Crore FY25 Total Revenue 1,500+ Customers 34+ Products 50+ Countries receive our exported products ICRA AA Stable Long-Term Rating 3 RES

165,000 MT

RESPONSIBLE CHEMISTRY PRODUCT DRIVEN EXPANSION India’s first integrated Polycarbonate plant (165,000 MT/yr) Total Investment of ₹8,500 Crore Actively developing new products and variants as well as

₹8,500 Crore

VEN EXPANSION India’s first integrated Polycarbonate plant (165,000 MT/yr) Total Investment of ₹8,500 Crore Actively developing new products and variants as well as seeking long-term contracts and strat

70%

boosting India’s chemical manufacturing and export growth Deepak Nitrite is transitioning to 60-70% renewable energy and embracing green chemistry to create safer, more eco- friendly products – E

INR 100 Crore

y FY27 Flexible manufacturing enables quick adaptation to changing market demands Invested over INR 100 Crore in a new world-class R&D Centre at Savli, Vadodara, to drive innovation in Life Sciences, Speci

₹235.8

onsistently rewarded shareholders Dividend as % of Face Value RESPONSIBLE CHEMISTRY MARKET CAP ₹235.8 bn. $2.7 bn* 31 Oct ‘25 ₹101.2 bn. $1.2 bn* 31 Oct ‘20 Special Final Interim 50% 225% 225%

₹101.2

s Dividend as % of Face Value RESPONSIBLE CHEMISTRY MARKET CAP ₹235.8 bn. $2.7 bn* 31 Oct ‘25 ₹101.2 bn. $1.2 bn* 31 Oct ‘20 Special Final Interim 50% 225% 225% 350% 375% 375% 375% FY20 FY

50%

RKET CAP ₹235.8 bn. $2.7 bn* 31 Oct ‘25 ₹101.2 bn. $1.2 bn* 31 Oct ‘20 Special Final Interim 50% 225% 225% 350% 375% 375% 375% FY20 FY21 FY22 FY23 FY24 FY25 *Conversion rate of ₹87.30

225%

CAP ₹235.8 bn. $2.7 bn* 31 Oct ‘25 ₹101.2 bn. $1.2 bn* 31 Oct ‘20 Special Final Interim 50% 225% 225% 350% 375% 375% 375% FY20 FY21 FY22 FY23 FY24 FY25 *Conversion rate of ₹87.30 per d

“Exports Revenue Mix for Q2 FY26 RESPONSIBLE CHEMISTRY Particulars (₹ Crore) Revenue EBITDA PBT Q2 FY26 Q2 FY25 Y-o-Y (%) Q1 FY26 Q-o-Q (%) H1 FY26 H1 FY25 Y-o-Y (%) 1,922 2,053 224 163 319 264 -6% -30% -38% 1,914 0.4% 3,836 4,239 214 155 5% 5% 438 318 647 539 -9% -32% -41% Performance Overview Deepak Group has delivered a resilient performance in Q2 FY26.”

“5% Q-o-Q Growth in PBT in Q2 FY26 The Group has confronted these headwinds by pivoting to non-traditional geographies, increasing emphasis on India, investing upstream, debottlenecking some capacities and protecting wallet share across its product range.”

“s r e b m u N y e K 7 RESPONSIBLE RESPONSIBLE CHEMISTRY CHEMISTRY Project Status ¢ Acid Unit: Expected to be fully operational by Q4 FY26 ¢ MIBK/MIBC Project: Progressing well and targeted for commissioning by the end of Q4 FY26.”

“REVENUE EBITDA 11 Commenting on the performance for Q2 FY26, Mr.”

“Q2 FY26 was marked by an increasingly demanding operating landscape, yet I am pleased to note that Deepak delivered a progressive performance on the back of agility and responsiveness of our teams.”

“• With our Nitric Acid plant set to be fully operational from Q4, there will be assured supply of inputs accompanied by an improved margin profile RESPONSIBLE CHEMISTRY Key Highlights • Phenolics segment delivered a strong performance, achieving 2% sequential revenue growth and sharply higher EBIT growth of 23% QoQ.”

Domestic

1

Mobile Health Units

1

Infrastructure

1

Livelihoods

1

Collaboration

1

Startup Support

1

Assessments

1

Domestic

Exports Revenue Mix for Q2 FY26 RESPONSIBLE CHEMISTRY Particulars (₹ Crore) Revenue EBITDA PBT Q2 FY26 Q2 FY25 Y-o-Y (%) Q1 FY26 Q-o-Q (%) H1 FY26 H1 FY25 Y-o-Y (%) 1,922 2,053 224 163 319 264 -6% -30% -38% 1,914 0.4% 3,836 4,239 214 155 5% 5% 438 318 647 539 -9% -32% -41% Performance Overview Deepak Group has delivered a resilient performance in Q2 FY26. Sequentially, revenues remained stable with a modest improvement in profitability. On a year-on-year basis, both revenue and profit declined, reflecting the vastly different operating conditions compared to the previous year. In the Phenolics business, we witnessed growth in volumes accompanied by better contribution due to lower feedstock prices. The Advanced Intermediates business has been impacted by the direct and indirect effect of US tariff actions and continued influx of underpriced Chinese products, which remains a major constraint on a broader sectoral rebound. 5% Q-o-Q Growth in PBT in Q2 FY26 The Group has confronted these

Mobile Health Units

Doorstep healthcare in tribal areas of Maharashtra and Gujarat; served 149,791 beneficiaries in FY 2024–25. Deepak Medical Centre: ₹11 Cr infrastructure support over 3 years to Medical Care Centre Trust. Community

Assessments

Voluntarily conducted evaluations of key projects for effectiveness and improvement. Focus Areas Education Healthcare Women Empowerment Livelihood and Skill Development Infrastructure Development Environment, Sanitation, and Water Conservation Impact Over 700,000 beneficiaries Presence across 25 districts, 5 states, and 2,000+ villages 75 capital assets created or acquired 18 About Us & Contact Details RESPONSIBLE RESPONSIBLE CHEMISTRY CHEMISTRY Deepak Nitrite Limited (NSE: DEEPAKNTR, BSE: 506401) is a leading chemical intermediates producer with a diversified portfolio that caters to the dyes and pigments, agrochemical, pharmaceutical, plastics, textiles, paper and home and personal care segments and petrol derivates intermediates - phenolics, acetone and IPA in India and overseas. Its products are manufactured across 6 locations, which are all accredited by Responsible Care. For further information, please contact: Somsekhar Nanda Chief Financial Officer Deepak Nitrite Limited Email: